Acute exacerbation of COPD: Factors associated with poor treatment outcome

Chest

Volumn 117, Issue 3, 2000, Pages 662-671

  Dewan, Naresh A ^a   Rafique, Salem ^a   Kanwar, Badar ^a   Satpathy, Hemant ^a   Ryschon, Kay ^b   Tillotson, Glenn S ^d   Niederman, Michael S ^c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d BAYER CORPORATION   (United States)

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Outcome factors

Indexed keywords

AMOXICILLIN; AMPICILLIN; COTRIMOXAZOLE; ERYTHROMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034018656     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.662     Document Type: Article

References (23)

1. 1 Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(suppl): 77-120
2. 2 Morbidity and mortality: chartbook on cardiovascular, lung, and blood diseases. Rockville, MD: National Heart Lung and Blood Institute, National Institutes of Health; May 1996; Publication No. 96-50
3. 3 Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204
4. 4 Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995; 273:957-960
5. 5 Ball P, Harris JM, Lowson D, et al. Acute Infective exacerbation of chronic bronchitis. Q J Med 1995; 88:61-68
6. 6 Balter MS, Hyland RH, Low DE, et al. Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Can Med Assoc J 1994; 151(suppl 10):5-23
7. 7 Destache CJ, Dewan NA, O'Donohue WJ, Jr, et al. Clinical and economic considerations in acute exacerbation of chronic bronchitis. J Antimicrob Chemother 1999; 43(Suppl A): 107-113
8. 8 Adams S, Mel J, Anzueto A. Effects of antibiotics on the recurrence rates of chronic obstructive pulmonary disease exacerbations [abstract]. Chest 1997; 112:22S
9. 9 American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Non-tuberculosis Respiratory Diseases. Am Rev Respir Dis 1962; 1962:85:762-768
10. 10 Efron B. The efficiency of logistic regression compared to normal discriminant analysis. J Am Stat Assoc 1975; 70:892-898
11. 11 Afifi AA, Clark V. Computer-aided multivariate analysis. Belmont, CA: Lifetime Learning Publications, 1984
12. 12 Chodosh S. Treatment of chronic bronchitis: state of the art. Am J Med 1991; 91(6A):87S-92S
13. 13 Niederman MS. Acute exacerbations of chronic bronchitis: the role of infection and the selection of appropriate therapy. Pulm Crit Care Update 1996; 11:1-7
14. 14 Higgins M. Epidemiology of pulmonary disease. In: Casaburi R, Petty TL, eds. Principles and practice of pulmonary rehabilitation. Philadelphia, PA: WB Saunders; 1993; 10-17
15. 15 Grossman RG, Mukherjee J, Vaughn D, et al. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 1998; 113:131-141
16. 16 Eller J, Ede A, Schaberg T, et al. Acute infective exacerbation of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113:1542-1548
17. 17 Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157:1698-1705
18. 18 Ball P, Make B. Acute exacerbations of chronic bronchitis: an international comparison. Chest 1998; 113(suppl):199S-204S
19. 19 Leeper KV, Jones AM, Tillotson G. The changing bacterial etiology of chronic obstructive pulmonary disease [abstract]. Chest 1997; 112(suppl):21S
20. 20 Doern GV, Brueggeman AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus Influenzae in the United States in 1994 and 1995 and detection of B-lactamase-positive strains resist to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41:292-297
21. 21 Doern GV, Brueggeman AB, Pierce G, et al. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40:2884-2886
22. 22 Doern GV, Brueggeman A, Holley Jr PH, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208-1213
23. 23 Smith CB, Golden CA, Kanner RE, et al. Association of viral and Mycoplasma Pneumoniae Infections with Acute Respiratory Illness in Patients with Chronic Obstructive Pulmonary Disease. Am Rev Respir Dis 1980; 121:225-232